Results 21 to 30 of about 3,126,496 (202)

QRISK3 Assessment Identified Essential Thrombocythemia Patients at High Risk of Thrombotic Events Regardless of Revised IPSET-T Score and JAK2 Mutational Status. [PDF]

open access: yesEJHaem
eJHaem, Volume 7, Issue 6, December 2026.
Duminuco A   +16 more
europepmc   +2 more sources

Extensive Cerebral Venous Sinus Thrombosis With Obstructive Hydrocephalus in a Young Female With Underlying Essential Thrombocythemia: A Case Report. [PDF]

open access: yesClin Case Rep
ABSTRACT Persistent symptoms suggestive of idiopathic intracranial hypertension despite standard therapy should prompt urgent neuroimaging to exclude cerebral venous sinus thrombosis. When CVST is confirmed without an obvious provoking factor, evaluation for underlying myeloproliferative neoplasms, including JAK2‐positive essential thrombocythemia, is ...
Nafea S   +6 more
europepmc   +2 more sources

Application of IPSET-thrombosis in 1366 Patients Prospectively Followed From the Spanish Registry of Essential Thrombocythemia [PDF]

open access: yes, 2023
Thrombosis; Essential thrombocythemiaTrombosi; Trombocitèmia essencialTrombosis; Trombocitemia esencialThe International Prognostic Score of thrombosis in Essential Thrombocythemia (IPSET-thrombosis) and its revised version have been proposed to guide ...
Velez Tenza, Patricia   +85 more
core   +1 more source

Thrombospondin in essential thrombocythemia [PDF]

open access: yesBlood, 1986
Abstract Essential thrombocythemia is a myeloproliferative disorder characterized by frequent bleeding and thrombotic complications. On a molecular level, two abnormalities of platelet thrombospondin have been identified: abnormal glycosylation of the intact 185,000-dalton chain has been detected and a shortened form of the ...
J, Lawler   +3 more
openaire   +3 more sources

CO‐Rebreathing in Essential Thrombocythemia and Polycythemia Vera. A Revival of an Old Methodology to Improve Diagnosis and Phlebotomy Decisions [PDF]

open access: yesCancer Med
ABSTRACT The diagnostic landscape for the Philadelphia‐negative myeloproliferative neoplasms (MPNs), particularly in distinguishing Essential Thrombocythemia (ET) from Polycythemia Vera (PV), is compromised. The gold standard for diagnosing PV—measurement of red cell mass (RCM) by radioisotope dilution—has been largely abandoned, leading to widespread ...
Hasselbalch H   +10 more
europepmc   +2 more sources

Essential thrombocythemia (ET) [PDF]

open access: yesAtlas of Genetics and Cytogenetics in Oncology and Haematology, 2011
The disease is a chronic myeloproliferative disorder originating from a mutated pluripotent stem cell capable of producing red blood cells, granulocytes and megakaryocytes. In some cases, B-lymphocyte involvement by the clonal proliferation was documented.
CUNEO, Antonio, CAVAZZINI, Francesco
openaire   +2 more sources

Essential thrombocythemia [PDF]

open access: yes, 1998
Review on Essential thrombocythemia, with data on clinics, and the genes ...
Huret, JL
core   +1 more source

Essential thrombocythemia presenting as digital ischemia [PDF]

open access: yes, 2017
Essential thrombocythemia is a myeloproliferative disease and is characterized by increased production of platelet and increased megakaryocytes in the bone marrow.
Md. Abdur Rahim   +5 more
core   +1 more source

Late‐Onset Chorea in JAK2‐Associated Essential Thrombocythemia [PDF]

open access: yes, 2021
Somatic mutations in JAK2 are associated with chronic myeloproliferative neoplasms (MPNs), including polycythemia vera, essential thrombocythemia, and primary myelofibrosis (PMF).
Mulroy, E   +17 more
core   +2 more sources

Systemic mastocytosis and essential thrombocythemia: Case report and literature overview [PDF]

open access: yes, 2019
Case report of a patient with essential thrombocythemia and mastocytosis and overview of the ...
Sandro Giannini   +13 more
core   +1 more source

Home - About - Disclaimer - Privacy